Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 2 | History Defined

Tilray (TLRY) Stock Surges To New 52-Week High On Strong Q1 Earnings Report

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings report. Here’s what investors need to know.

Benzinga

Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt

Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.

Benzinga

As Tilray Expands Its Medical Cannabis Business, Should You Buy, Sell, or Hold TLRY Stock?

Tilray’s rapid expansion in Germany and the launch of five new EU-GMP-certified craft products put it at the forefront of Europe’s largest medical cannabis market, but current analyst targets remain below the stock’s price.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?

Tilray's stock surge, fueled by political commentary and a technical squeeze, is now focusing market attention on its strong financial health.

MarketBeat

What's Going On With Tilray Brands Stock Tuesday?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading lower Tuesday morning, giving back a portion of the previous session’s explosive gains. The stock is experiencing a correction after surging over 35% on Monday, a rally ignited by a weekend social media post from President Donald Trump.

Benzinga

Tilray Stock Is Trading Higher Monday: What's Going On?

Tilray Brands, Inc. (NASDAQ: TLRY) shares are trading higher Monday after President Donald Trump shared a video that discussed potential medical benefits of CBD for seniors.

Benzinga

Cannabis stocks soar after Trump shares video promoting drug’s use for seniors

Video posted on Truth Social touts CBD as a ‘gamechanger’ and promotes Medicaid coverage of CBD products

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Are Cannabis Stocks Ready for a Long-Term Rebound?

Cannabis stocks are soaring today in light of some positive remarks from President Donald Trump. What implications could this have for the industry’s long-term prospects?

Barchart

What's Going On With Tilray Stock Today?

Tilray Brands, Inc. (NASDAQ:TLRY) shares gained ground on Thursday after the marijuana company’s medical division expanded its portfolio in Germany with three newly certified cannabis strains.

Benzinga

Tilray’s Stock Price Is Growing Like a Weed. Here’s Why, and What Comes Next.

With rescheduling on the table, here are two option trades to play the potential spike in TLRY stock.

Barchart

What's Going On With Tilray Brands (TLRY) Stock?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Tuesday, with the stock up 39% over the past week. Here’s what investors need to know.

Benzinga

Tilray Stock Continues To Rally After Hours: Here's Why Its Moving

Pharmaceuticals and cannabis lifestyle company, Tilray Brands Inc. (NASDAQ:TLRY), rallied 20.87% on Monday and is now showing no signs of slowing down, with another 4.32% gain after hours, as broad-based tailwinds begin to align in the company’s favor.

Benzinga

Jefferies Just Raised Its Tilray Stock Price Target 33%. Should You Buy TLRY Here?

Tilray stock extends gains as Jefferies raises its price target on the cannabis firm to $2. But caution is warranted as TLRY shares are already up some 300% versus their year-to-date low.

Barchart

Tilray Brands (TLRY) Stock Is Surging Monday: What's Going On?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading sharply higher Monday morning, bolstered by a positive note from Jefferies and growing optimism around significant U.S. cannabis reform this year. Jefferies analyst Kaumil Gajrawala maintained a Buy rating on the stock while raising the price target from $1.50 to $2.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Tilray's High Hopes: The Catalyst Driving Cannabis Stocks

Tilray's stock rally is fueled by market anticipation of a U.S. cannabis rescheduling decision, a key catalyst for the entire cannabis sector's future.

Barchart

Is Tilray Stock a Buy, Sell, or Hold for August 2025?

With global ambitions expanding and potential cannabis reclassification, should investors brace for upside? Or prepare for another volatile season?

Barchart

Dear Tilray Stock Fans, Mark Your Calendars for September 21

Tilray says it requested an extension to regain compliance with minimum listing requirements of the Nasdaq Exchange. Here’s why TLRY shares are still not worth owning at current levels.

Benzinga

Tilray Eyes Reverse Stock Split As Nasdaq Listing Compliance Pressure Mounts

Tilray Brands, Inc. (NASDAQ:TLRY) shares slipped Thursday after the company said it is seeking more time from Nasdaq to restore compliance with the exchange’s continued listing rules tied to its per-share price.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Going On With Tilray Stock Today?

Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading higher on Tuesday.

Benzinga

Tilray Surges 14% After Hours On Trump Cannabis Reclassification

Tilray Brands Inc. (NASDAQ:TLRY) stock surged by 14.13%, to $1.05 during after-hours on Monday. This surge follows a report suggesting that President Donald Trump is contemplating reclassifying marijuana, a move that could significantly impact the industry.

Benzinga

Following Mixed Q4 Results, Tilray's Turnaround Strategy Is Put To The Test

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading lower Tuesday morning after the global cannabis and consumer goods company reported fourth-quarter revenue that fell short of analyst expectations. Here’s what investors need to know.

Benzinga

Tilray Misses Q4 Revenue, Beats EPS Estimates, Shares Slide

Tilray Brands Inc (NASDAQ:TLRY) reported fourth-quarter financial results for fiscal 2025 after the market close on Monday. Here’s a rundown of the report.

Benzinga

Palantir, The Trade Desk, Tilray, Sonnet Biotherapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks traded mostly flat on Monday as investors reacted to President Donald Trump’s announcement of a 30% tariff on all imports from the EU and Mexico, effective August 1. Inflation worries ahead of Tuesday's CPI data also weighed on sentiment. By the close, the Dow rose 0.2% to 44,459.65,…

MarketBeat

Tilray Shares Blazing: What's Behind the 55% Rally This Month?

Tilray's recent 55% rally may draw investor attention, but do the potential benefits outweigh the continued risks of this cannabis leader?

Benzinga

Tilray Brands Stock Is Climbing Monday: What's Driving The Action?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Monday morning, building on a recent rally fueled by heavy trading volume and company announcements. The cannabis giant’s stock has been a focal point for investors in recent sessions, driven by a combination of high short interest and positive industry news.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.